Open original FDA record ↗Recall record
- FDA identifier
- Z-0884-2026
- Company in FDA record
- Illumina, Inc.
- FDA classification date
- Dec 4, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An instrument intended for sequencing DNA libraries with in vitro diagnostic assays is used with reagent kits including flow cells that have flow cell gaskets that have a quality issue, which may lead to flow cell leaks during runs, which could cause run failures, that may result in: No/insufficient data output, instrument fluidics clogs, toxic substance exposure to user.
Source facts
- Action
- On 10/28/2025, recall notices were emailed to customers who were asked to do the following: Dispose of reagents per local regulations. See Instrument Reference Guide: https://support.illumina.com/downloads/nextseq-550dx-instrument-reference-guide-1000000009513.html Illumina requests that this notice be communicated to all relevant personnel within your organization and to any external organization that has received the potentially affected reagent kits. If you experienced a run failure in a previous run using an affected flow cell, or experience leaking issues please contact Illumina Technical Support at techsupport@illumina.com Complete and return the verification form via email to techsupport@illumina.com
- Initiated
- 2025-10-28
- Root cause
- Vendor change control
- Distribution
- Worldwide - US Nationwide distribution in the states of PA, NJ, CA, NC, UT, IL, MD, NY, VA, WV, SD, TX, AL, SC, TN, KY, MI and the countries of DK, SA, FR, DE, IT, CN, PL, GB, TH, GR, VN, BE, ES, IL, KR, AU, CH, BG, NL, IE, TW, TR, CZ, HU, NO, FI, JP, SG, LU, AT, AE, ZA, PT, LT, SE.
- Recall number
- Z-0884-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217151
- FDA classified
- 2025-12-04
- Recall event number
- 97913